LANXESS completes acquisition of Brazilian biocide manufacturer IPEL

Cologne
Specialty chemicals company LANXESS today, February 3, 2020, completed the acquisition of Itibanyl Produtos Especiais Ltda. (IPEL). The competent anti-trust authorities approved the transaction beginning of January.

IPEL with headquarters in Jarinu, São Paulo, is one of Brazil’s leading biocide manufacturers and generated sales in the lower double-digit million euro range in 2018. With the acquisition, LANXESS is strengthening its position as one of the world’s leading manufacturers of antimicrobial active ingredients and formulations. In addition to around 100 employees and the production facility, LANXESS has taken over the Brazilian company’s laboratory facilities.

IPEL generates the majority of its sales with biocides and specialty chemicals for the paint and coating industry. The product portfolio also includes preservatives and fungicides for process control in water treatment as well as active ingredients for disinfection and cleaning agents.

MORE ABOUT THIS TOPIC

PRESS RELEASE
Since August 1, 2013, specialty chemicals Group LANXESS is steering its global business from the LANXESS Tower in Cologne.

LANXESS increases sales and earnings in the third quarter of 2026

November 05, 2026
PRESS RELEASE
Woman put the cream on skin.

LANXESS Introduces Cosmelin Biodegradable Ester Portfolio for Cosmetics and Personal Care

October 26, 2026
PRESS RELEASE
Packshot Rely+On® Medero

LANXESS will present its new disinfectant, Rely+On Medero, for the first time at Medica 2026

October 22, 2026
PRESS RELEASE
Packshot Rely+On® Medero

LANXESS launches highly effective disinfectant for the medical sector

October 20, 2026
PRESS RELEASE
PIR insulation panel, aluminium-laminated

LANXESS sharpens flame-retardant portfolio for rigid PU and PIR insulation

September 22, 2026